Opening book details…
About this Medicine article
P-111 PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification by Tabernero, J. (author);Bekaii-Saab, T. (author);Safont Aguilera, M. (author);Cubillo, A. (author);Garcia-Carbonero, R. (author);Limon, L. (author);Rodríguez-Salas, N. (author);Tournigand, C. (author);Borg, C. (author);Raghav, K. (author);Finley, G. (author);Strickler, J. (author);Beier, F. (author);Salim, S. (author);Esser, R. (author);Liu, E. (author);Adrian, S. (author);López-López, C. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Tabernero, J. (author);Bekaii-Saab, T. (author);Safont Aguilera, M. (author);Cubillo, A. (author);Garcia-Carbonero, R. (author);Limon, L. (author);Rodríguez-Salas, N. (author);Tournigand, C. (author);Borg, C. (author);Raghav, K. (author);Finley, G. (author);Strickler, J. (author);Beier, F. (author);Salim, S. (author);Esser, R. (author);Liu, E. (author);Adrian, S. (author);López-López, C. (author)
- Publisher
- Elsevier BV
- Published
- 2021
- Field
- Medicine (Health Sciences)